Three years ago, the FDA found so many violations at a Nephron Pharmaceuticals manufacturing facility that the U.S. regulator admitted in a warning letter the issues were so numerous they couldn’t all ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback